GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB

被引：1

作者：

Lassman, A. ^{[1
]}

Alexander, B. ^{[2
,3
]}

Berry, D. ^{[4
]}

Buxton, M. ^{[5
]}

Cavenee, W. ^{[6
]}

Colman, H. ^{[7
]}

De Groot, J. ^{[8
]}

Ellingson, B. ^{[9
]}

Gordon, G. ^{[5
]}

Hyddmark, E. M., V ^{[5
]}

Khasraw, M. ^{[10
]}

Lim, M. ^{[11
]}

Mellinghoff, I ^{[12
]}

Mikkelsen, T. ^{[13
]}

Perry, J. ^{[14
]}

Powell, A. ^{[5
]}

Sulman, E. ^{[15
]}

Tanner, K. ^{[16
]}

Weller, M. ^{[17
]}

Yung, W. K. A. ^{[18
]}

Blondin, N. ^{[19
]}

Brenner, A. ^{[20
]}

Butt, O. ^{[21
]}

de la Fuente, M., I ^{[22
]}

Drappatz, J. ^{[23
]}

Iwamoto, F.

Kim, L. ^{[24
]}

Lee, E. ^{[25
]}

Mantica, M. ^{[26
]}

Nabors, B. ^{[27
]}

Newton, H. ^{[28
]}

Schiff, D. ^{[29
]}

Walbert, T. ^{[13
]}

Weathers, S. ^{[30
]}

Cloughesy, T. ^{[9
]}

Wen, P. Y. ^{[31
]}

机构：

[1] Columbia Univ, New York, NY USA

[2] Harvard Med Sch, Boston, MA USA

[3] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[4] Berry Consultants, Austin, TX USA

[5] Global Coalit Adapt Res, Larkspur, CA USA

[6] UCSD, La Jolla, CA USA

[7] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[8] UCSF, San Francisco, CA USA

[9] UCLA, Los Angeles, CA USA

[10] Duke Univ, Med Ctr, Durham, NC USA

[11] Stanford Univ, Stanford, CA USA

[12] Mem Sloan Kettering, New York, NY USA

[13] Henry Ford Hlth, Detroit, MI USA

[14] Univ Toronto, Toronto, ON, Canada

[15] NYU, Grossman Sch Med, New York, NY USA

[16] Natl Brain Tumor Soc, Newton, MA USA

[17] Univ Hosp Zurich, Zurich, Switzerland

[18] UT MD Anderson Canc Ctr, Houston, TX USA

[19] Yale Univ, New Haven, CT USA

[20] Texas Oncol, Austin, TX USA

[21] Washington Univ, St Louis, MO USA

[22] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA

[23] Hillman Canc Ctr, Pittsburgh, PA USA

[24] Mt Sinai Hosp, New York, NY USA

[25] Dana Farber Canc Inst, Boston, MA USA

[26] Univ Pittsburgh, Pittsburgh, PA USA

[27] Nivers Alabama Birmingham, Birmingham, AL USA

[28] Univ Hosp Cleveland, Med Ctr, Cleveland, OH USA

[29] Univ Virginia, Charlottesville, VA USA

[30] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[31] Dana Farber Canc Inst, Larkspur, CA USA

来源：

NEURO-ONCOLOGY | 2024年 / 26卷

关键词：

D O I：

10.1093/neuonc/noae144.079

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OS09.7.A

引用

页码：V26 / V27

页数：2

共 50 条

[21] Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM
Kurt A. Jaeckle
Karla V. Ballman
Caterina Giannini
Paula J. Schomberg
Matthew M. Ames
Joel M. Reid
Renee M. McGovern
Stephanie L. Safgren
Evanthia Galanis
Joon H. Uhm
Paul D. Brown
Julie E. Hammack
Robert Arusell
Daniel A. Nikcevich
Roscoe F. Morton
Donald B. Wender
Jan C. Buckner
Journal of Neuro-Oncology, 2010, 99 : 73 - 80
[22] PHASE 2 CLINICAL TRIAL OF VAL-083 IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM
Chen, Zhong-ping
Guo, Cheng-Cheng
Yang, Qun-ying
Wu, Shao-xiong
Li, Jia-Wei
Bacha, Jeffrey
Johnson, Greg
Langlands, John
Schwartz, Richard
Kwan, Claire
Kanekal, Sarath
Steino, Anne
Lopez, Lorena
Brown, Dennis
NEURO-ONCOLOGY, 2020, 22 : 60 - 60
[23] RTOG 0525: Molecular correlates from randomized phase III trial of newly diagnosed glioblastoma (GBM).
Aldape, K. D.
Wang, M.
Sulman, E. P.
Cahill, D. P.
Hegi, M.
Colman, H.
Jones, G.
Chakravarti, A.
Mehta, M. P.
Andrews, D. W.
Long, L.
Diefes, K.
Heathcock, L.
Jenkins, R.
Schultz, C. J.
Gilbert, M. R.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[24] Phase II NCCTG trial of RT plus irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM
Jaeckle, Kurt A.
Ballman, Karla V.
Giannini, Caterina
Schomberg, Paula J.
Ames, Matthew M.
Reid, Joel M.
McGovern, Renee M.
Safgren, Stephanie L.
Galanis, Evanthia
Uhm, Joon H.
Brown, Paul D.
Hammack, Julie E.
Arusell, Robert
Nikcevich, Daniel A.
Morton, Roscoe F.
Wender, Donald B.
Buckner, Jan C.
JOURNAL OF NEURO-ONCOLOGY, 2010, 99 (01) : 73 - 80
[25] A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Saran, Frank
James, Allan
McBain, Catherine
Jefferies, Sarah
Harris, Fiona
Cseh, Agnieszka
Pemberton, Karine
Schaible, Jennifer
Bender, Shaun
Brada, Michael
NEURO-ONCOLOGY, 2018, 20 : 20 - 20
[26] Preliminary results from a multicenter, phase II, randomized, noncomparative clinical trial of radiation and temozolomide with or without vandetanib in newly diagnosed glioblastoma (GBM).
Quant, E. C.
Batchelor, T.
Lassman, A. B.
Schiff, D.
Kaley, T. J.
Wong, E.
Mikkelsen, T.
Drappatz, J.
Norden, A. D.
Beroukhim, R.
Weiss, S. E.
Alexander, B. M.
Sceppa, C.
Gerard, M.
Hallisey, S. D.
Bochacki, C. A.
Smith, K. H.
Muzikansky, A.
Wen, P. Y.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[27] Final results of phase 2 trial of personal dendritic cell (DC) vaccines loaded with autologous tumor antigens (ATA) in newly diagnosed glioblastoma (GBM)
Bota, Daniela Annenelie
Piccioni, David Eric
Taylor, Thomas H.
LaRocca, Renato V.
Aiken, Robert D.
Kong, Xiao-Tang
Lopez, Katrina L.
Keirstead, Hans S.
Nistor, Gabriel I.
Dillman, Robert O.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[28] Interim results of a phase I/IIa trial of a therapeutic CMV vaccine against recurrent glioblastoma (GBM).
Lassman, Andrew B.
Reardon, David A.
Lee, Eudocia Quant
Iwamoto, Fabio Massaiti
Diaz-Mitoma, Francisco
Anderson, David E.
Wen, Patrick Y.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[29] Tumor treating fields added to standard chemotherapy in newly diagnosed glioblastoma (GBM): Final results of a randomized, multi-center, phase III trial
Stupp, Roger
Hegi, Monika E.
Idbaih, Ahmed
Steinberg, David M.
Lhermitte, Benoit
Read, William
Toms, Steven A.
Barnett, Gene H.
Nicholas, Garth
Kim, Chae-Yong
Fink, Karen
Salmaggi, Andrea
Lieberman, Frank S.
Zhu, Jay-Jiguang
Taylor, Lynne
Stragliotto, Giuseppe
Hottinger, Andreas F.
Kirson, Eilon D.
Weinberg, Uri
Palti, Yoram
Ram, Zvi
CANCER RESEARCH, 2017, 77
[30] Phase II trial of talampanel in conjunction with standard radiation (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)
Grossman, S. A.
Ye, X.
Chamberlain, M. C.
Mikkelsen, T.
Batchelor, T. T.
Desideri, S.
Piantadosi, S.
Fine, H. A.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →